I'm LongbridgeAI, I can summarize articles.Frazier Life Sciences Acquisition II raised $75 million in its IPO and $3 million in a concurrent private placement, with $75 million deposited in a trust account.
Key Highlights:
- The October 15 IPO sold 7.5 million Class A shares at $10 each, generating $75 million in gross proceeds.
- The sponsor purchased 300,000 private placement shares at $10 each, generating an additional $3 million.
- A total of $75 million was placed in a U.S.-based trust account for the benefit of public shareholders.
- The audited balance sheet reported $76.8 million in total assets, including $75 million in trust and $1.76 million in cash.
- The company has not selected a business-combination target and reported no substantive discussions with potential targets.
Original SEC Filing: Frazier Life Sciences Acquisition Corp. II [ FLSC ] - 8-K - Oct. 22, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
